Assignee
BONAFIDE HEALTH LLC
US·11 granted patents·10 pending applications·2 citations·filing 2017–2025
Top patents by PatentIndex Score
21 records- 0196US11850308B2Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplementBONAFIDE HEALTH LLC·Filed 2021·Granted Dec 26, 2023·2 cites·15 claims
- 0290US12274791B2Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplementBONAFIDE HEALTH LLC·Filed 2023·Granted Apr 15, 2025·0 cites·6 claims
- 0387US2025114417A1Maca compositions and methods of useBONAFIDE HEALTH LLC·Filed 2024·Application pending·0 cites
- 0485US12465625B2Maca compositions and methods of useBONAFIDE HEALTH LLC·Filed 2023·Granted Nov 11, 2025·0 cites·10 claims
- 0583US12070482B2Curcumin compositions and methods of use as an NK3 antagonistBONAFIDE HEALTH LLC·Filed 2023·Granted Aug 27, 2024·0 cites·30 claims
- 0683US2024408165A1Curcumin compositions and methods of use as an nk3 antagonistBONAFIDE HEALTH LLC·Filed 2024·Application pending·0 cites
- 0780US2025275997A1Compositions Comprising S-Adenosylmethionine and a Gallic Acid EsterBONAFIDE HEALTH LLC·Filed 2025·Application pending·0 cites
- 0879US12239623B2Sleep-improving compositions and methods of useBONAFIDE HEALTH LLC·Filed 2024·Granted Mar 4, 2025·0 cites·18 claims
- 0979US11857594B2Curcumin compositions and methods of use as an NK3 antagonistBONAFIDE HEALTH LLC·Filed 2022·Granted Jan 2, 2024·0 cites·12 claims
- 1077US12357655B2Polyglutamic acid compositions and methods of usingBONAFIDE HEALTH LLC·Filed 2023·Granted Jul 15, 2025·0 cites·22 claims
- 1177US2025262267A1Curcumin compositions and methods of use as an nk3 antagonistBONAFIDE HEALTH LLC·Filed 2025·Application pending·0 cites
- 1276US2024342147A1Magnesium picolinate compositions and methods of useBONAFIDE HEALTH LLC·Filed 2024·Application pending·0 cites
- 1375US12201661B2Maca compositions and methods of useBONAFIDE HEALTH LLC·Filed 2021·Granted Jan 21, 2025·0 cites·1 claims
- 1474US12048712B2Beta-adrenergic agonist and muscarinic antagonist compositions and methods of usingBONAFIDE HEALTH LLC·Filed 2023·Granted Jul 30, 2024·0 cites·22 claims
- 1571US2025312372A1Polyglutamic acid compositions and methods of usingBONAFIDE HEALTH LLC·Filed 2025·Application pending·0 cites
- 1670US2024285666A1Beta-adrenergic agonist and muscarinic antagonist compositions and methods of usingBONAFIDE HEALTH LLC·Filed 2024·Application pending·0 cites
- 1769US12324796B2Sleep-improving compositions and methods of useBONAFIDE HEALTH LLC·Filed 2025·Granted Jun 10, 2025·0 cites·25 claims
- 1868US2025248961A1Sleep-improving compositions and methods of useBONAFIDE HEALTH LLC·Filed 2025·Application pending·0 cites
- 1967US2024050354A1Polyglutamic acid compositions and methods of usingBONAFIDE HEALTH LLC·Filed 2023·Application pending·0 cites
- 2065US12016849B2Magnesium picolinate compositions and methods of useBONAFIDE HEALTH LLC·Filed 2017·Granted Jun 25, 2024·0 cites·15 claims
- 2156US2024108048A1Probiotic and folic acid compositions and methods of usingBONAFIDE HEALTH LLC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BONAFIDE HEALTH LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →